The Future of Cardiac Monitoring is Being Built.

Be Part of It.

JVPLabs is advancing toward FDA clearance with a validated, patent-protected platform that addresses the most expensive and preventable condition in healthcare. We welcome conversations with aligned strategic partners, health systems and hospitals and clinical partners.

Work With Us
$0B
Annual CHF Cost
Annual cost of heart failure to the US healthcare system — the single largest Medicare cost driver
$0K
Per Readmission Loss
Average direct hospital loss per 30-day CHF readmission — in excess of DRG payment
0%
Discharged Congested
Of CHF patients are discharged while still congested — a leading driver of preventable readmissions
1 in 0
Readmitted in 30 Days
CHF patients are readmitted within 30 days of discharge — a penalty hospitals can no longer afford

Invest. Partner. Shape the Future.

Join Us in Transforming Heart Failure Care

Strategic Partners

We welcome conversations with strategic partners at any stage. Reach out to learn more about our clinical validation, regulatory pathway, IP portfolio, and commercial strategy.

Health Systems & Hospitals

Connect with our clinical team to explore how JVPClinic can reduce readmissions, standardize heart failure care, and improve outcomes across your patient population.

Ready to Partner with JVPLabs?

JVPLabs is advancing toward FDA clearance with a validated, patent-protected platform — and we're building the partnerships that will take JVPClinic to market. Whether you're an investor, a health system, or a clinical leader, we'd love to start a conversation.

Just fill out this form and we’ll be happy to speak with you!

Clinical Partners

Interested in trial participation, early access, or strategic collaboration? We’re actively building partnerships that will define the next generation of hemodynamic monitoring!